LNAI
Price:
$1.3
Market Cap:
$23.14M
A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.
Industry
Biotechnology
IPO Date
2025-09-30
Stock Exchange
NASDAQ
Ticker
LNAI
According to Lunai Bioworks Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.16. This represents a change of -101.35% compared to the average of 11.86 of the last 4 quarters.
The mean historical PE Ratio of Lunai Bioworks Inc. over the last ten years is -0.17. The current -0.16 PE Ratio has changed 9.31% with respect to the historical average. Over the past ten years (40 quarters), LNAI's PE Ratio was at its highest in in the March 2025 quarter at 48.91. The PE Ratio was at its lowest in in the December 2024 quarter at -1.27.
Average
-0.17
Median
-0.18
Minimum
-0.32
Maximum
0
Discovering the peaks and valleys of Lunai Bioworks Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 206.18%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -100.00%
Minimum Annual PE Ratio = -0.32
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 0 | -100.00% |
| 2024 | -0.25 | -22.22% |
| 2023 | -0.32 | 206.18% |
The current PE Ratio of Lunai Bioworks Inc. (LNAI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.19
5-year avg
-0.17
10-year avg
-0.17
Lunai Bioworks Inc.’s PE Ratio is less than Adaptimmune Therapeutics plc (-0.08), greater than Ernexa Therapeutics Inc. (-0.59), greater than Moleculin Biotech, Inc. (-0.28), greater than BioLineRx Ltd. (-1.69), greater than GeoVax Labs, Inc. (-0.31), greater than Adlai Nortye Ltd. (-0.25), greater than SeaStar Medical Holding Corporation (-0.69), greater than Tharimmune, Inc. (-0.59), greater than Apollomics, Inc. (-0.30), greater than Lipocine Inc. (-3.68),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.08 | $75.16M | |
| -0.59 | $10.28M | |
| -0.28 | $9.32M | |
| -1.69 | $14.17M | |
| -0.31 | $9.73M | |
| -0.25 | $37.48M | |
| -0.69 | $10.01M | |
| -0.59 | $86.56M | |
| -0.30 | $16.27M | |
| -3.68 | $16.63M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lunai Bioworks Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lunai Bioworks Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Lunai Bioworks Inc.'s PE Ratio?
How is the PE Ratio calculated for Lunai Bioworks Inc. (LNAI)?
What is the highest PE Ratio for Lunai Bioworks Inc. (LNAI)?
What is the 3-year average PE Ratio for Lunai Bioworks Inc. (LNAI)?
What is the 5-year average PE Ratio for Lunai Bioworks Inc. (LNAI)?
How does the current PE Ratio for Lunai Bioworks Inc. (LNAI) compare to its historical average?